178 cases, organized by subtopic. Choose a subtopic below to browse its cases directly, rather than scrolling the full section.
Antihypertensive selection, resistant disease, and blood-pressure management in pregnancy and special populations.
Medical management and surgical-threshold decisions across the major native and prosthetic valve lesions.
Antianginal, antiplatelet, and revascularization-strategy decisions in stable and acute coronary disease.
Guideline-directed medical therapy, device timing, and drug selection across HFrEF and HFpEF.
Anticoagulant selection, bridging, and reversal across atrial fibrillation, VTE, and mechanical valves.
Rate vs. rhythm control and antiarrhythmic drug selection in atrial and ventricular arrhythmias.
Statin intensity, non-statin add-ons, and lipid-lowering strategy across risk categories.
Device therapy and channelopathy management, including pacemakers, ICDs, and inherited arrhythmia syndromes.
Single and dual antiplatelet strategy, duration, and agent selection across coronary and cerebrovascular disease.
Medical management of claudication and limb ischemia alongside revascularization timing.
Diagnosis and drug therapy for pericarditis, effusion, and constrictive physiology.
Antianginal drug selection and escalation in chronic and refractory angina.
Fibrinolytic and primary-PCI decision-making in acute coronary syndrome.
Pulmonary vasodilator selection and escalation across the WHO functional classes.
Drug therapy in hypertrophic, dilated, and genetically defined cardiomyopathies.
Cardioprotective and cardiotoxicity-management decisions in patients on cancer therapy.
Pharmacologic management of vasovagal and autonomic-mediated syncope.
Perioperative continuation, holding, and bridging of cardiovascular medications around surgery.
Medical therapy aimed at slowing progression in genetically mediated aortopathy.
Pharmacologic management of venous thromboembolism and chronic venous disease.